Related Experiment Video
Updated: Apr 17, 2026
09:01
The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques
Published on: July 3, 2014
24.1K
Evaluating treatment options for common bovine diseases using published data and clinical experience
Annette O'Connor1, Virginia Fajt2
1Veterinary Medical Research Institute, College of Veterinary Medicine, Iowa State University, Building 4, Ames, IA 50010, USA.
The Veterinary Clinics of North America. Food Animal Practice
|February 24, 2015
Summary
Clinicians use various sources for treatment efficacy information, but bias potential and assessment vary by source. Understanding these differences is crucial for informed clinical decision-making.
Area of Science:
- Medical Information Science
- Clinical Decision-Making
- Evidence-Based Practice
Background:
- Clinicians rely on diverse information sources to guide treatment efficacy assessments.
- The potential for bias and the ability to evaluate it differ significantly across these sources.
- Clinical context and individual impressions influence treatment decisions but can be subject to bias.
Purpose of the Study:
- To analyze the various sources clinicians use for treatment efficacy information.
- To evaluate the differential potential for bias and assessability of bias across information sources.
- To highlight the role of clinical setting and background in treatment decision-making.
Main Methods:
- Review of literature and discussion of different information sources.
- Analysis of bias potential and assessment methods for each source type.
- Exploration of the influence of clinical context on efficacy perception.
Main Results:
- Information sources like cohort studies, case reports, and narrative reviews present varying levels of bias.
- Clinical impressions, while valuable, are susceptible to cognitive and contextual biases.
- The ability to critically appraise information differs based on the source's inherent structure and methodology.
Conclusions:
- Awareness of source-specific biases is essential for accurate treatment efficacy evaluation.
- A critical approach to information sources, including clinical impressions, improves evidence-based practice.
- Understanding the limitations of each information source enhances clinical judgment and patient care.
Related Concept Videos
01:16Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
219
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
219
01:30Acute Pancreatitis II: Clinical Manifestations and Management
1.1K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.1K
01:13Bioequivalence studies: Biowaivers
414
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
414